Skip to main content
    I

    iRhythm Technologies Inc (IRTC)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $90.83
    -1.08 (-1.18%)

    Market Cap: $3.05B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    iRhythm Technologies Inc (IRTC) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect iRhythm Technologies (IRTC) to earn $1.27 per share in the fiscal year ending Dec 31, 2026, on revenue of $893.10M. Of 16 analysts, 16 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 3 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 16 ratings average 1.81, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.

    RatingAnalystsShare
    Strong Buy318.8%
    Buy1381.3%
    Hold00.0%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Buy
    Total analysts
    16

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus rises 22.8% and revenue estimates rise 19.8%.

    Fiscal year ending Dec 31, 2026
    $1.27
    EPS consensus, revenue $893.10M
    Fiscal year ending Dec 31, 2027
    $1.56
    EPS consensus, revenue $1.07B
    Next report
    Feb 17, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$1.27$1.15 to $1.4310$893.10M$891.20M to $895.76M16
    Dec 31, 2027$1.56$0.85 to $2.0811$1.07B$1.06B to $1.08B16

    Quarterly Estimates

    The EPS consensus falls from $0.16 for the quarter ending Dec 31, 2026 to -$0.12 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$0.16$0.05 to $0.3118$252.87M$241.08M to $263.13M18
    Mar 31, 2027-$0.12-$0.35 to $0.2310$243.49M$237.60M to $256.67M12

    Estimate Revisions

    Across the 3 periods below, the last 30 days brought 1 upward and 3 downward EPS revisions.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202613
    Fiscal year ending Dec 31, 202700
    Quarter ending Mar 31, 202700

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 119.0% from $0.58.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026$1.27$0.45$0.47$0.58$0.58+116.5%
    Fiscal year ending Dec 31, 2027$1.56$1.20$1.19$1.19$1.18+32.6%
    Quarter ending Mar 31, 2027-$0.12-$0.20-$0.20-$0.19-$0.15N/A

    Frequently Asked Questions About IRTC

    What is the IRTC stock forecast?

    Consensus analyst estimates put iRhythm Technologies's EPS at $1.27 for the fiscal year ending Dec 31, 2026, on revenue of $893.10M. The consensus rating from 16 analysts is Buy.

    How do analysts rate IRTC stock?

    Of 16 analysts covering iRhythm Technologies, 3 rate it Strong Buy, 13 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.

    What EPS do analysts expect from IRTC next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $1.27, with estimates from $1.15 to $1.43 from 10 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $1.56, with estimates from $0.85 to $2.08 from 11 analysts.

    What revenue do analysts expect from iRhythm Technologies next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $893.10M, with estimates from $891.20M to $895.76M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $1.07B, with estimates from $1.06B to $1.08B.

    How many analysts cover IRTC?

    16 analysts rate iRhythm Technologies stock, and 10 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.